CTVABasic Materials · Agricultural InputsCTVA Stock Forecast: Corteva, Inc. Price Predictions for 2026-2027
The 10 Wall Street analysts covering Corteva, Inc. hold a median 12-month price target of $17 — +46.2% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 82 of 100 as at 26 Oct 2026 — inside the top quartile. Here, the model and the Street point the same way.
CTVA stock analysis: one number for the whole business
Consensus tells you what everyone already believes. The model scores Corteva, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.
Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested
Value (98): The shares cost little relative to the profits and assets behind them — which can mean the market is too gloomy, or that the business really is in trouble.
Accruals (52): A large share of reported profit has not shown up as cash, or the balance sheet is expanding quickly — both tend to unwind.
Size (17): Larger than most of the companies we track — more scrutinised, less often mispriced.
Built and run by Aslam Ghouse, an ex-Goldman Sachs systematic trader with 15+ years in markets.
CTVA stock forecast 2026-2027: analyst price targets & predictions
The bullish and bearish analyst opinions on CTVA, reported as data — targets and ratings, the market's view beside the model's.
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Data provided by Twelve Data
The green dot is the last close — the median target sits +46.2% from it.
Of the 20 most recent actions, 2 moved their price target up and 2 moved it down.
| Date | Firm | Action | Rating | Target |
|---|---|---|---|---|
| 6 Oct 2026 | JP Morgan | Upgrade | Overweight | $83 → $19 |
| 18 Sept 2026 | Argus Research | Reiterates | Buy | $91 |
| 17 Sept 2026 | Citigroup | Maintains | Neutral | $86 → $91 |
| 16 Sept 2026 | BMO Capital | Maintains | Outperform | $100 → $95 |
| 16 Sept 2026 | RBC Capital | Reiterates | Outperform | $103 |
| 16 Sept 2026 | UBS | Maintains | Neutral | $85 → $90 |
| 11 Sept 2026 | Keybanc | Initiates | Sector Weight | — |
| 18 Aug 2026 | UBS | Maintains | Neutral | — |
| 3 Aug 2026 | BMO Capital | Maintains | Outperform | — |
| 3 Aug 2026 | Citigroup | Maintains | Neutral | — |
| 3 Aug 2026 | JP Morgan | Maintains | Neutral | — |
| 3 Aug 2026 | UBS | Maintains | Neutral | — |
| 23 July 2026 | Oppenheimer | Maintains | Outperform | — |
| 21 July 2026 | RBC Capital | Maintains | Outperform | — |
| 20 July 2026 | B of A Securities | Maintains | Buy | — |
| 14 July 2026 | Mizuho | Maintains | Outperform | — |
| 2 July 2026 | Mizuho | Maintains | Outperform | — |
| 11 June 2026 | Barclays | Maintains | Overweight | — |
| 9 June 2026 | UBS | Maintains | Neutral | — |
| 28 May 2026 | Morgan Stanley | Maintains | Overweight | — |
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
This page is one stock. Monday covers all of them.
CTVA appears in the Radar on the weeks it earns a place.
- Market Radar, every Monday: the week's biggest rank moves across ~4,600 US stocks, and the reason for each.
- The AI build-out map, free: every AI company we track, part by part, and one part in full with each verdict.
CTVA vs the S&P 500
Both lines are total return — dividends reinvested — so the comparison is honest on both sides.
Over the twelve months to 27 Oct 2026, Corteva, Inc. returned +29.0% against +13.5% for the S&P 500, dividends included.
Download this chart as an image — free to reuse; link this page as the source.
Data provided by Twelve Data
CTVA analyst estimate revisions
Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.
Corteva, Inc. (CTVA) financial data
A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.
- Trailing P/E
- 7.7×
- Price / sales
- 1.7×
- Price / book
- 1.0×
- EV / EBITDA
- 16.8×
Cheaper than 62% of US stocks
Cheaper than 56% of US stocks
Cheaper than 69% of US stocks
Cheaper than 19% of US stocks
- Revenue growth (YoY)
- −1.2%
- Earnings growth (YoY)
- −11.6%
- Gross margin
- —
- Operating margin
- 12.8%
- Net margin
- 2.8%
Higher than 26% of US stocks
Higher than 26% of US stocks
Higher than 69% of US stocks
Higher than 54% of US stocks
- Return on equity
- 4.5%
- Return on assets
- 2.6%
- Dividend yield
- 0.9%
Higher than 53% of US stocks
Higher than 62% of US stocks
Higher than 69% of US dividend payers
Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.
Corteva, Inc. (CTVA) statistics: revenue, profit & scale
The headline figures, each with its date. Every row carries its own link — cite it straight from here.
Corteva, Inc. has a market value of $8.3B and an enterprise value of $11.4B.
Revenue in the twelve months to 31 Mar 2026: $17.9B. The latest quarter shrank 1.2% year on year.
Net income over the same four quarters: $1.2B, a 6.6% net margin.
Diluted earnings per share, trailing twelve months: $1.70.
Free cash flow in the twelve months to 31 Mar 2026: $2.0B, after $578.0M of capital spending.
Corteva, Inc. spent $1.1B on share buybacks and $176.0M on dividends in the twelve months to 31 Mar 2026.
Trailing P/E: 7.7×; forward P/E: 11.0× — the forward figure prices analyst consensus estimates, not reported earnings.
Forward dividend yield: 0.87%, paying out 44% of earnings.
Corteva, Inc. employs 21,500 people — $832K of revenue per employee.
Data provided by Twelve Data
CTVA vs competitors
The nearest names by industry and size, scored by the same model — like for like.
Look up any of the roughly 4,600 stocks we score.
The rank is the raw material. Whether the rules would actually own Corteva, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →
Frequently asked questions about CTVA stock
What is the CTVA stock price forecast for 2026-2027?
The 10 Wall Street analysts covering Corteva, Inc. have a median 12-month price target of $17, with estimates ranging from $14 to $20. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.
Is CTVA stock a buy right now?
Of the 10 analysts covering Corteva, Inc., 8 rate it a Buy, 2 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks Corteva, Inc. 82 out of 100 across roughly 4,600 US stocks as at 26 Oct 2026. None of this is personal advice — it does not consider your circumstances.
How does Ticker Nerd's model rank CTVA?
As at 26 Oct 2026, Corteva, Inc. ranks 82 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Value (98 of 100).
Will CTVA stock go up?
No one can know that. What the data says: the median 12-month target from 10 analysts implies +46.2% from the last close, and Ticker Nerd's factor model ranks Corteva, Inc. 82 out of 100 as at 26 Oct 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.
What is the CTVA stock forecast for 2030?
No analyst covering Corteva, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for CTVA are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $14 to $20 over the next 12 months.
How has CTVA stock performed over the past year?
Corteva, Inc. returned +29.0% over the 12 months to 27 Oct 2026, with dividends reinvested. Past performance does not indicate future returns.
What does Corteva, Inc. do?
Corteva Inc. is a global agricultural science company that develops and supplies seed and crop protection solutions for farmers and agribusinesses.
About Corteva, Inc.
Corteva Inc. is a global agricultural science company that develops and supplies seed and crop protection solutions for farmers and agribusinesses. Its product portfolio includes advanced seed genetics, trait technologies, herbicides, insecticides, fungicides, biologicals, and seed-applied technologies designed to support crop performance, pest control, and plant health. The company serves a wide range of agricultural markets, including field crops such as corn and soybeans, as well as specialty crops and pasture management needs. Corteva Inc. also provides digital agriculture tools that help improve decision-making across planting, protection, and productivity workflows. With operations across major farming regions, the company plays a significant role in the agricultural inputs market by supplying products and services that support modern crop production and farm resilience.
CEO Mr. Luther Clarence Kissam IV · 21,500 employees · United States · https://www.corteva.com